Aim: To assess the suppressive effects of glabridin (GLA) on colorectal cancer (CRC) cells. Methods: After treating cultured CRC cell lines in vitro with different concentrations of GLA, cell proliferation was examined through cell counting kit-8 (CCK-8) and 5-ethynyl-2 '-deoxyuridine (EdU) assays, and cell migration and invasion were determined by Transwell migration and invasion assays. Quantitative polymerase chain reaction (qPCR) and Western blotting were carried out to detect expression levels of intercellular adhesion molecule 1 (ICAM1) mRNA (messenger ribonucleic acid) and phosphorylated (p)-signal transducer and activator of transcription 3 (STAT3) protein. ICAM1-associated downstream pathways were analyzed via the LinkedOmics database. Results: GLA inhibited proliferation, migration, and invasion of SW620 and HT-29 cells. Additionally, ICAM1 was found as a downstream target of GLA, and GLA suppressed the expression levels of ICAM1 and p-STAT3. ICAM1 overexpression reversed the effects of GLA on CRC cell multiplication, migration, invasion, and p-STAT3 protein expression. Conclusions: GLA restrains the malignant phenotypes of CRC cells via regulating ICAM1/p-STAT3 signaling pathway.
基金:
China Postdoctoral Sci-ence Foundation Project [2021M692613]
语种:
外文
WOS:
中科院(CAS)分区:
出版当年[2022]版:
大类|4 区医学
小类|4 区医学:研究与实验4 区生理学4 区内分泌学与代谢4 区免疫学
最新[2025]版:
无
JCR分区:
出版当年[2021]版:
Q3MEDICINE, RESEARCH & EXPERIMENTALQ3PHYSIOLOGYQ4ENDOCRINOLOGY & METABOLISMQ4IMMUNOLOGY
最新[2023]版:
Q4ENDOCRINOLOGY & METABOLISMQ4IMMUNOLOGYQ4MEDICINE, RESEARCH & EXPERIMENTALQ4PHYSIOLOGY
第一作者单位:[1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan 430030, Hubei, Peoples R China
通讯作者:
通讯机构:[1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan 430030, Hubei, Peoples R China[2]Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430030, Hubei, Peoples R China
推荐引用方式(GB/T 7714):
Guo Qiuyun,Ding Qianshan.Glabridin Inhibits the Malignancy of CRC Cells by Inhibiting ICAM1/p-STAT3 Signaling Pathway[J].JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS.2023,37(8):4041-4049.doi:10.23812/j.biol.regul.homeost.agents.20233708.398.
APA:
Guo, Qiuyun&Ding, Qianshan.(2023).Glabridin Inhibits the Malignancy of CRC Cells by Inhibiting ICAM1/p-STAT3 Signaling Pathway.JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS,37,(8)
MLA:
Guo, Qiuyun,et al."Glabridin Inhibits the Malignancy of CRC Cells by Inhibiting ICAM1/p-STAT3 Signaling Pathway".JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS 37..8(2023):4041-4049